MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancer.

Autor: Lotta von Boehmer, Lukas Keller, Ashkan Mortezavi, Maurizio Provenzano, Giovanni Sais, Thomas Hermanns, Tullio Sulser, Achim A Jungbluth, Lloyd J Old, Glen Kristiansen, Maries van den Broek, Holger Moch, Alexander Knuth, Peter J Wild
Jazyk: angličtina
Rok vydání: 2011
Předmět:
Zdroj: PLoS ONE, Vol 6, Iss 7, p e21366 (2011)
Druh dokumentu: article
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0021366
Popis: The cancer-testis (CT) family of antigens is expressed in a variety of malignant neoplasms. In most cases, no CT antigen is found in normal tissues, except in testis, making them ideal targets for cancer immunotherapy. A comprehensive analysis of CT antigen expression has not yet been reported in prostate cancer. MAGE-C2/CT-10 is a novel CT antigen. The objective of this study was to analyze extent and prognostic significance of MAGE-C2/CT10 protein expression in prostate cancer. 348 prostate carcinomas from consecutive radical prostatectomies, 29 castration-refractory prostate cancer, 46 metastases, and 45 benign hyperplasias were immunohistochemically analyzed for MAGE-C2/CT10 expression using tissue microarrays. Nuclear MAGE-C2/CT10 expression was identified in only 3.3% primary prostate carcinomas. MAGE-C2/CT10 protein expression was significantly more frequent in metastatic (16.3% positivity) and castration-resistant prostate cancer (17% positivity; p
Databáze: Directory of Open Access Journals